Evidence map›Paper›PMID 30357555›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2019

Systematic vs. on-demand early palliative care in gastric cancer patients: a randomized clinical trial assessing patient and healthcare service outcomes.

Emanuela Scarpi, Monia Dall'Agata, Vittorina Zagonel, Teresa Gamucci, Raffaella Bertè, Elisabetta Sansoni, Elena Amaducci, Chiara Maria Broglia, Sara Alquati, Ferdinando Garetto and 17 more

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01996540 (The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers), which is not on this map. Cited by 31 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01996540 nacompletednot on this map

The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial.

TypeinterventionalSponsorIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSRan2012 to 2018Enrolled394ConditionsPancreatic Neoplasm, Gastric NeoplasmArmsInterventional arm: Early best palliative care
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Timing and contents of early palliative care preferred by patients with advanced cancer in Japan: an Internet-based questionnaire survey.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Timely integration of palliative care. the reality check. a retrospective analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Emanuela ScarpiUnit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014, Meldola, FC, Italy. emanuela.scarpi@irst.emr.it.ORCID http://orcid.org/0000-0001-7230-9267
Monia Dall'AgataUnit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014, Meldola, FC, Italy.
Vittorina ZagonelMedical Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
Teresa GamucciOncology Unit, SS Trinità Hospital, Sora, ASL Frosinone, Italy.
Raffaella BertèPalliative Care, Oncology Department, Guglielmo da Saliceto Hospital, AUSL, Piacenza, Italy.
Elisabetta SansoniPalliative Care Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei, Tumori (IRST) IRCCS, Meldola, Italy.
Elena AmaducciPalliative Care and Hospice Unit, AUSL Romagna, Cesena, Italy.
Chiara Maria BrogliaOncology Unit, Fondazione IRCCS, Policlinico San Matteo, Pavia, Italy.
Sara AlquatiPalliative Care Unit, Arcispedale S. Maria Nuova-IRCCS, Reggio Emilia, Italy.
Ferdinando GarettoMedical Oncology Unit, Presidio Humanitas Gradenigo, Torino, Italy.
Stefania SchiavonMedical Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
Silvia QuadriniOncology Unit, SS Trinità Hospital, Sora, ASL Frosinone, Italy.
Elena OrlandiMedical Oncology Unit, Oncology Department, Guglielmo da Saliceto Hospital, Piacenza, Italy.
Andrea Casadei GardiniDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Silvia RuscelliDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Daris FerrariOncology Unit, San Paolo Hospital, Milan, Italy.
Maria Simona PinoMedical Oncology Unit, Oncology Department, Azienda USL Toscana Centro, S. Maria Annunziata Hospital, Florence, Italy.
Roberto BortolussiPalliative care and Pain Therapy Unit, Aviano National Cancer Institute, Aviano, Italy.
Federica NegriMedical Oncology Unit, Azienda Socio Sanitaria Territoriale, Cremona, Italy.
Silvia StragliottoMedical Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
Filomena NarducciOncology Unit, SS Trinità Hospital, Sora, ASL Frosinone, Italy.
Martina ValgiustiDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Alberto FarolfiDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Oriana NanniUnit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014, Meldola, FC, Italy.
Romina RossiPalliative Care Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei, Tumori (IRST) IRCCS, Meldola, Italy.
Marco MaltoniPalliative Care Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei, Tumori (IRST) IRCCS, Meldola, Italy.
Early Palliative Care Italian Study Group (EPCISG)

Funding

Italian Ministry of Health RF-2011-02350971
6 · The paper itself

Abstract

purposeEarly palliative care (EPC) has shown a positive impact on quality of life (QoL), quality of care, and healthcare costs. We evaluated such effects in patients with advanced gastric cancer.

methodsIn this prospective, multicenter study, 186 advanced gastric cancer patients were randomized 1:1 to receive standard cancer care (SCC) plus on-demand EPC (standard arm) or SCC plus systematic EPC (interventional arm). Primary outcome was a change in QoL between randomization (T0) and T1 (12 weeks after T0) in the Trial Outcome Index (TOI) scores evaluated through the Functional Assessment of Cancer Therapy-Gastric questionnaire. Secondary outcomes were patient mood, overall survival, and family satisfaction with healthcare and care aggressiveness.

resultsThe mean change in TOI scores from T0 to T1 was - 1.30 (standard deviation (SD) 20.01) for standard arm patients and 1.65 (SD 22.38) for the interventional group, with a difference of 2.95 (95% CI - 4.43 to 10.32) (p = 0.430). The change in mean Gastric Cancer Subscale values for the standard arm was 0.91 (SD 14.14) and 3.19 (SD 15.25) for the interventional group, with a difference of 2.29 (95% CI - 2.80 to 7.38) (p = 0.375). Forty-three percent of patients in the standard arm received EPC.

conclusionsOur results indicated a slight, albeit not significant, benefit from EPC. Findings on EPC studies may be underestimated in the event of suboptimally managed issues: type of intervention, shared decision-making process between oncologists and PC physicians, risk of standard arm contamination, study duration, timeliness of assessment of primary outcomes, timeliness of cohort inception, and recruitment of patients with a significant symptom burden. CLINICAL

trial registrationClinicalTrials.gov (NCT01996540).

Indexed as

AdultAgedAged, 80 and overFemaleHospice and Palliative Care NursingHumansMaleMiddle AgedPalliative CareQuality of LifeStomach NeoplasmsAggressiveness in end of lifeEarly palliative careQuality of careQuality of life

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.